À retenir
Of 23 studies of leucine or leucine-enriched protein (1.2-6 g leucine/day) in sarcopenia, 13 were randomized placebo-controlled trials; the supplements were well tolerated and mainly improved lean muscle mass. Strength results were mixed and physical performance was rarely studied, so the benefit that matters most in daily life is unproven.
Study design
Revue des preuves
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Sarcopenia, the age-related loss of muscle mass, strength and function, is hard to treat, and nutrition is a promising approach. Leucine is an amino acid that helps trigger muscle building. The authors reviewed what leucine supplementation does for the main sarcopenia criteria: strength, lean mass and physical performance.
Population et méthode
Systematic review following PRISMA guidelines. Databases searched included PubMed/Medline, Embase, EBSCO, Cochrane, Lilacs and Dialnet. Of 163 articles consulted, 23 met the inclusion criteria, testing leucine or leucine-enriched protein in sarcopenia, and 13 of those were randomized, placebo-controlled trials (RCTs). The review covered older people with sarcopenia from aging and from specific disorders. The abstract does not report participant numbers, trial durations or pooled effect sizes.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Leucine or leucine-enriched protein (1.2-6 g leucine/day) was well tolerated and significantly improved sarcopenia in older people, mainly by increasing lean muscle mass. Most protocols that showed this also gave vitamin D.
- 2Effects on muscular strength were mixed.
- 3Effects on physical performance have seldom been studied.
- 4For sarcopenia linked to specific disorders, the most promising results were in post-stroke rehabilitation and in people with liver cirrhosis.
Limites et incertitude
- 1Only 13 of the 23 studies were randomized placebo-controlled trials, so about 10 were of other designs that give weaker evidence.
- 2Because most protocols also gave vitamin D, the lean-mass gains cannot be attributed to leucine alone.
- 3Studies measured sarcopenia in different ways, and the authors call for trials that use the criteria recommended by official Working Groups.
- 4The abstract gives no effect sizes, durations or sample sizes, and this reading is based on the abstract only.
Mise en perspective
Leucine-rich protein may help older adults preserve lean mass, but it did not clearly improve strength, and the abstract does not say whether it helps people walk, rise from a chair or avoid falls. Supplements are not a substitute for resistance exercise and enough dietary protein. Anyone with sarcopenia, liver disease or a recent stroke should check with their clinician before adding supplements.
Vos données
Grip strength, chair-stand ability, walking speed and body weight or body composition scale trends are more useful than a single number. Consumer body-composition scales estimate lean mass imprecisely, so compare readings only on the same device, at the same time of day and hydration.
Comprendre ce type de preuve
Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Objective
Treating sarcopenia remains a challenge, and nutritional interventions present promising approaches. We summarize the effects of leucine supplementation in treating older individuals with sarcopenia associated with aging or to specific disorders, and we focus on the effect of leucine supplementation on various sarcopenia criteria, e.g., muscular strength, lean mass, and physical performance.
Methods
A literature search for articles related to this topic was performed on the relevant databases, e.g., the PubMed/Medline, Embase, EBSCO, Cochrane, Lilacs, and Dialnet. The identified articles were reviewed according to Preferred Reporting Items for Systematic reviews and meta-analyses (PRISMA) guidelines.
Results
Of the 163 articles we consulted, 23 met our inclusion criteria, analysing the effect of leucine or leucine-enriched protein in the treatment of sarcopenia, and 13 of these studies were based on randomized and placebo-controlled trials (RCTs). In overall terms, the published results show that administration of leucine or leucine-enriched proteins (range 1.2-6 g leucine/day) is well-tolerated and significantly improves sarcopenia in elderly individuals, mainly by improving lean muscle-mass content and in this case most protocols also include vitamin D co-administration. The effect of muscular strength showed mix results, and the effect on physical performance has seldom been studied. For sarcopenia-associated with specific disorders, the most promising effects of leucine supplementation are reported for the rehabilitation of post-stroke patients and in those with liver cirrhosis. Further placebo-controlled trials will be necessary to determine the effects of leucine and to evaluate sarcopenia with the criteria recommended by official Working Groups, thereby limiting the variability of methodological issues for sarcopenia measurement across studies.
Sources et attribution
Beneficial Effects of Leucine Supplementation on Criteria for Sarcopenia: A Systematic Review.
Martínez-Arnau FM, Fonfría-Vivas R, Cauli O.
Nutrients · 2019-10-17
DOI: 10.3390/nu11102504 ↗PubMed · 31627427 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

